Professional Documents
Culture Documents
JNP Cissus
JNP Cissus
org/jnp Article
ABSTRACT: Bioassay-guided investigation of the Saudi medicinal and edible plant Cissus
rotundifolia yielded seven metabolites, including the new sucrose diester cissuxinoside (1)
and the unprecedented cissoic acid (2), belonging to unusual classes of secondary
Downloaded via Shagufta Perveen on November 29, 2020 at 20:09:01 (UTC).
Chart 1
coumaroyl)-β-D-glucopyranose (7), responsible for the activity Table 1. 1H and 13C NMR Data of Cissuxinoside (1) in
of the extract. Methanol-d4
6.72, d (8.5)
δC, type
131.1, C
129.5, CH
aqueous EtOH and the total extract was dissolved in H2O and 3=5 6.52, d (8.5) 115.3, CH
partitioned against EtOAc and then n-BuOH. This latter phase, 4 155.3, C
selected on the basis of bioactivity (vide infra), was subjected 7 4.23a 44.5, CH
to bioassay-guided fractionation on Sephadex LH-20 and RP- 8 3.95, dd (10.3, 7.8) 44.4, CH
HPLC to afford the new cissuxinoside (1) and cissoic acid (2), 9 174.0, C
large amounts of the C-glycosides 3−5, 4-O-β-D-glucopyr- 1′ 131.1, C
anosyl-Z-4-coumaric acid (6), and 1-O-(4-coumaroyl)-β-D- 2′ = 6′ 6.84, d (8.5) 129.9, CH
glucopyranose (7). 3′ = 5′ 6.57, d (8.5) 115.5, CH
Cissuxinoside (1) was obtained as a yellow amorphous solid 4′ 155.3, C
with a molecular formula of C30H34O15 as determined by HR- 7′ 4.18, dd (10.3, 4.7) 45.5, CH
ESIMS. The 1H NMR data of 1 (Table 1) showed four two- 8′ 3.81a 44.6, CH
proton doublets between δH 6.50 and 6.85, a pattern suggestive 9′ 174.3, C
of two 1,4-disubstituted phenyl moieties, and a series of signals 1″ 5.34, d (3.5) 94.3, CH
located between δH 3.00 and 5.35, including an anomeric 2″ 3.40, dd (9.3, 3.5) 73.0, CH
oxymethine at δH 5.34. All the proton signals were associated 3″ 3.74, t (9.3) 73.7, CH
with the directly linked carbon atoms through 2D HSQC data, 4″ 3.09, t (9.3) 72.7, CH
while analysis of the COSY spectrum arranged the proton 5″ 4.02a 72.6, CH
multiplets in five distinct spin systems, as shown in Figure 1. In 6″a 4.82a 67.2, CH2
addition to the two anticipated disubstituted phenyl rings, an 6″b 3.80a
AA′BB′ system of methine proton signals resonating around δH 1‴ 3.85, s 61.5, CH2
3.80−4.25 was disclosed (corresponding carbon atoms 2‴ 105.0 C
resonated in the range δC 44−46), typical values of a 3‴ 4.22a 78.9, CH
tetrasubstituted cyclobutane moiety. Moreover, an α-glucopyr- 4‴ 4.00a 77.2, CH
anosyl system could be deduced from the small 3J1″,2″ and the 5‴ 4.04a 80.3, CH
large values of the H-2″/H-3″, H-3″/H-4″, and H-4″/H-5″ 6‴a 4.31, dd (10.8, 8.5) 68.0, CH2
coupling constants. The presence of a ketose sugar unit was 6‴b 4.22a
a
inferred from the 2D HMBC spectrum, which showed Overlapped with other signals.
correlations of both H2-1‴ and H-3‴ with an anomeric carbon
3299 https://dx.doi.org/10.1021/acs.jnatprod.0c00597
J. Nat. Prod. 2020, 83, 3298−3304
Journal of Natural Products pubs.acs.org/jnp Article
Figure 2. (Left) COSY (red) and HMBC (blue arrows) detected for cissoic acid (2); (right) dominant rotamer around the C-9/C-10 single bond.
ROESY correlations and homonuclear and heteronuclear experimental ECD spectrum permitted unequivocal assign-
coupling constants. The 2D NMR HETLOC experiment was ment of the (9S,10R) absolute configuration of compound 2.
used to measure exact values for the required 2JC,H and 3JC,H.
Following the Murata model,12 the small 3J9,10 value, the large
3
JC‑8/H‑10 (7.9 Hz) and 2JC‑9/H‑10 (−6.0 Hz), and the small
3
JC‑11/H‑9 (1.8 Hz) indicated that the methyl group at C-10 and
the O-Glu group at C-9 must possess the relative orientation as
shown in Figure 2. The ROESY correlations H3-14/H2-8, H-9/
H-10, and H2-8/H2-11 also supported the 9S,10R/9R,10S
relative configuration.
Having assumed the D-configuration of the sugar unit,
determination of the absolute configuration at C-9 and C-10
would completely define the stereostructure of cissoic acid (2).
The lack of functional groups that could be readily derivatized
with chiral auxiliaries prompted us to proceed with a
comparison of the experimental and TDDFT-simulated
electronic circular dichroism (ECD) spectra.
Since the dominant rotamer around the C-9/C-10 bond of 2
had been previously identified, the conformers of 2 resulting
from free rotation about the C-10/C-11 and C-8/C-9 bonds
were selectively investigated using the Gaussian 09 software.
This systematic search afforded 80 conformers, which were Figure 3. Comparison between experimental (dashed line) and
geometrically optimized at the DFT level using a mpw1pw91 calculated (9S,10R blue line, 9R,10S red line) ECD spectra for cissoic
functional and 6-31G(d) basis set. The relative energies of the acid (2).
different conformers were calculated, and the equilibrium
room-temperature Boltzmann-based populations were thus Cissoic acid (2) is an unprecedented glucosylated and
obtained. As shown in Table 3, conformers 1 and 2 account for conjugated C12 dicarboxylic acid bearing two methyl groups at
C-4 and C-10. The single related, although nonglycosylated,
Table 3. Relative Gibbs Free Energy and Relative diacid analogue of 2 present in the literature was reported
Population of the Main Rotamers around the C-10/C-11 about 50 years ago from the immature seeds of Phaseolus
and C-8/C-9 Bonds of Cissoic Acid (2) multif lorus.14 Cissoic acid (2) could derive from a cytochrome
ϕ C12−C11− ϕ C10−C9− ΔG % P-450-mediated ω-oxidation of a dimethylated and hydroxy-
conformer C10−C9 C8−C7 (kcal/mol) pop. lated dodecatrienoic acid. In this sense, it is interesting to
1 −60.10 −68.10 0.00 59.9 notice that a compound similar to the postulated substrate for
2 −150.10 −68.10 0.42 29.4 this oxidation, 11-hydroxy-4-methyl-2E,4E,6E-dodecatrienoic
3 74.90 −68.10 2.10 1.7 acid, has been reported from fermentations of a zygomycete of
4 −60.10 66.90 2.30 1.2 the genus Mucor sp.15
5 −105.10 −68.10 2.35 1.1 Compound 3, with a molecular formula of C26H28O14, as
6 150.10 66.90 2.57 0.8 assigned by HR-ESIMS data, was identified as vitexin-2″-O-β-
7 −150.10 66.90 2.57 0.8 D-arabinofuranoside by comparison of its spectroscopic data
8 −150.10 −23.10 2.58 0.8 with those reported for a flavone C-glycoside isolated from
9 −60.10 156.90 2.79 0.5 Cotoneaster thymaefolia.16 A complete set of 2D NMR spectra
was acquired to obtain complete 1H and 13C NMR assignment,
absent in ref 16 and now reported in the Experimental Section,
about 90% of the populated ones, and the remaining seven Compound 4, with a molecular formula of C26H28O15, as
conformers are those possessing energies within 3 kcal/mol of assigned by HR-ESIMS data, was assigned as a congener of 3
the lowest energy conformation and therefore are significantly differing in the presence of an additional oxygenated carbon on
populated. the aglycone moiety. Accordingly, 1H NMR resonances of the
The excitation energies as well as the oscillator and rotatory sugar moiety of 4 almost exactly matched those of 3, while the
strengths of the electronic excitations were calculated for the two compounds differed for the flavone moiety, with 4
nine conformational families using the TDDFT methodology showing the typical 1H NMR pattern of luteolin. A detailed
and weighed according to the Boltzmann population. Thus, the investigation of 2D NMR spectra supported the identification
ECD spectra for (9S,10R) and (9R,10S) were obtained as of 4 as orientin-2″-O-β-D-arabinofuranoside. The single report
shown in Figure 3. The agreement of the first with the of this compound is a patent describing its isolation from
3301 https://dx.doi.org/10.1021/acs.jnatprod.0c00597
J. Nat. Prod. 2020, 83, 3298−3304
Journal of Natural Products pubs.acs.org/jnp Article
Figure 4. (Left) Glucose uptake of HuH7 cells treated for 1 h with the indicated amount of insulin (control), fractions (2.0 mg/mL) and
compounds 1−7 (800 μg/mL), or vehicle (DMSO) (data are representative of n = 3 measurements, shown as mean ± SD; ***p < 0.001). (Right)
Dose−response curve for 7 promoting glucose uptake in HuH7 cells. The graph is representative of three independent experiments (mean of three
replicates ± SD).
Deschampsia antarctica and its antineoplastic activity.17 Since other concomitant mechanisms likely concur in defining the
no NMR data were available in the patent, a full 1H and 13C marked antidiabetic effect of C. rotundifolia extract.
NMR assignment of 4 was needed, and it is reported in the
Experimental Section.
Three further compounds were identified as isovitexin-2′-O-
■ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations (MeOH)
β-D-glucopyranoside (5),18 4-O-β-D-glucopyranosyl-Z-4-cou- were measured at 589 nm on a P2000 Jasco (Dunmow, UK)
maric acid (6),19 and 1-O-(4-coumaroyl)-β-D-glucopyranose polarimeter. ECD spectra were recorded on a J-710 spectropolarim-
(7)20 by comparison of their experimental and reported eter (Jasco) equipped with J-710 for Windows software (Jasco). LR-
and HR-ESIMS experiments were performed on an LTQ-Orbitrap
physical data.
mass spectrometer equipped with an ESI interface. NMR spectra were
All the compounds obtained from purification of the recorded on a Bruker Avance Neo 700 MHz (700 and 175 MHz for
bioactive fractions of the n-BuOH extract were evaluated for 1
H and 13C NMR, respectively). Chemical shifts are referenced to the
their activity in the promotion of glucose uptake in hepatic residual solvent signal (methanol-d4: δH 3.31, δC 49.0; DMSO-d6: δH
cells. The fluorescently labeled nonmetabolizable glucose 2.50, δC 39.5). Homonuclear 1H connectivities were determined by
analogue 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2- COSY experiments; one-bond heteronuclear 1H−13C connectivities
deoxyglucose (2-NBDG) was used to directly monitor the by the HSQC experiment; and two- and three-bond 1H−13C
uptake of the carbohydrate. Similarly to unlabeled glucose, the connectivities by gradient-HMBC experiments optimized for a 2,3J
value of 8 Hz. Through-space 1H connectivities were obtained using a
probe is transported into the cytoplasm by the family of ROESY experiment with a mixing time of 200 ms. The HETLOC
glucose transporters (GLUTs). However, due to the data were acquired on a 700 MHz NMR with the dipsi2etgpjcsix1
replacement of the 2′-hydroxy group in this position, 2- pulse program. Default acquisition parameters were used except for
NBDG cannot isomerize to fructose-6-phosphate and accu- the following modifications: td (f2) = 4096; td (f1) = 256; ns = 64;
mulates in the cell without proceeding along the glycolytic cnst2 = 140.0; cnst16 = 1.0; gpz1 = 13.0%; gpz2 = 19.0%; gpz3 =
pathway. As shown in Figure 4, 1 h treatment with 7 (800 mg/ 30.0%. The HETLOC spectrum was zero-filled to 8192 and 2048 in
the F2 and F1 dimensions, respectively. Column chromatography was
L) promoted glucose uptake in HuH7 (2.0 ± 0.2 over vehicle). performed on a Sephadex LH-20 column (Pharmacia, Uppsala,
On the contrary, the other tested compounds 1−6 failed in Sweden). RP-HPLC-UV−vis separations were performed on an
stimulating glucose uptake. The amount of glucose uptake Agilent instrument, using a 1260 Quat Pump VL system, equipped
upon treatment with 7 was comparable to that promoted by 10 with a 1260 VWD VL UV−vis detector, Supelco Ascentis C18, 5 μ 10
and 100 nM insulin (1.9 ± 0.1 and 2.2 ± 0.1, respectively), mm × 250 mm columns, and a Rheodyne injector. HPLC-RI
and, to a certain extent, the coumaroyl glucoside 7 might separations were performed on a Knauer (Berlin, Germany) 1800
stimulate GLUT transporters using an insulin-like mechanism. apparatus equipped with a refractive index detector and LUNA
(normal-phase, SI60, or reverse-phase RP18, 250 mm × 4 mm)
Dose−response experiments revealed that 7 promotes glucose (Phenomenex) columns. Thin-layer chromatography (TLC) was
uptake with an EC50 value of 7.7 ± 0.1 μM (Figure 4). performed on plates coated with silica gel 60 F254 Merck, 0.25 mm.
1-O-(4-Coumaroyl)-β-D-glucopyranose (7) had been re- TLC were analyzed using n-BuOH/HOAc/H2O (60:15:25, v/v) as
ported to exert anti-inflammatory activity via Akt phosphor- eluent and Ce(SO4)2 in H2SO4 as spray reagent.
ylation,21 but it had never been correlated to the antidiabetic PBS (A0965-9010), CaCl2 (A3779-1000), and TritonX-100
activity of plant extracts. Interestingly, compound 7 has (A1388-0500) were all from Applichem (Germany). Insulin
(I6634), {2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-
recently been detected in the most important plant of the
glucose} (2-NBDG), 2-deoxyglucose (2-DG), (4′,6-diamidino-2-
Vitaceae family (the same family as C. rotundifolia), namely, phenylindole) (DAPI), and bovine serum albumin (BSA) were
grape (Vitis vinifera) and in wine.22 from Sigma-Aldrich (Germany). Formaldehyde (7040) was from J. T.
In summary, a bioassay-guided purification of C. rotundifolia Baker (The Netherlands).
extracts revealed the presence of the new cissuxinoside (1) and Plant Material. C. rotundifolia samples were collected in October
cissoic acid (2), belonging to unusual classes of secondary 2017 in Jizan (southern Saudi Arabia) and identified by Dr.
metabolites. In addition, three rare glycosylflavones (3−5) Rajakrishnan, Department of Botany and Microbiology, College of
Science, King Saud University, Riyadh, Saudi Arabia. A voucher
were fully characterized, and for 3 and 4 NMR data are specimen of the plant has been deposited in the herbarium of College
reported here for the first time. This study identified 1-O-(4- of Science, King Saud University, Saudi Arabia (KSU No. 24329).
coumaroyl)-β-D-glucopyranose (7) as the main compound Extraction and isolation. C. rotundifolia aerial parts (4.0 kg)
responsible for the glucose uptake stimulation effect. However, were air-dried at room temperature in the shade and ground using a
3302 https://dx.doi.org/10.1021/acs.jnatprod.0c00597
J. Nat. Prod. 2020, 83, 3298−3304
Journal of Natural Products pubs.acs.org/jnp Article
blender. The obtained powder was defatted in n-hexane (2 × 3 L, 8 h 120.7 (C-6′), 116.4 (C-5′), 115.6 (C-3), 114.8 (C-2′), 109.9 (C-1‴),
each) and extracted with 80% aqueous EtOH (5 × 2 L, 8 h each) at 104.0 (C-8, C-10), 99.2 (C-6), 84.6 (C-4″′), 83.0 (C-2′′′), 82.7 (C-
room temperature. The EtOH extract was filtered and evaporated to 5′′), 80.6 (C-3′′), 77.3 (C-2′′), 77.2 (C-3′′′), 73.6 (C-1′′), 71.8 (C-
obtain a dried material (300 g), which was partitioned between H2O 4′′), 62.9 (C-6′′), 60.8 (C-5′′′); ESIMS m/z 579 [M − H]−;
and EtOAc, and then between H2O and n-BuOH, to afford EtOAc HRESIMS m/z found 579.5778 (calcd for C26H27O15 579.5770).
(34.0 g) and n-BuOH (23.0 g) phases. The BuOH phase, selected on ECD Calculations. DFT calculations were performed using the
the basis of bioactivity (see Figure 4), was chromatographed on a Gaussian09 package (Multiprocessor). A systematic conformational
Sephadex LH-20 column, eluted with MeOH to afford 70 fractions of search for cissoic acid (2) around the C-10/C-11 and C-8/C-9 bonds
20 mL each. Fractions 33, 49−66, 67/68, and 69/70 were shown to was carried out at the mpw1pw91 level using the 6-31G(d) basis set.
be the most active in preliminary biological assays (data not shown) All the conformers obtained were subsequently optimized at the
and were further purified by HPLC on a Supelco Ascentis C18 mpw1pw91 level using the 6-31G(d,p) basis set. TDDFT calculations
column. Fraction 33 was separated by semipreparative HPLC were run using the functional B3LYP and the basis set 6-31G(d,p)
(CH3OH/H2O, 3:2, flow rate 2.5 mL/min) to afford cissoic acid including at least 30 excited states in all cases and using the IEF-PCM
(2, 7.3 mg, tR 11 min) and two subfractions, whose further solvation method to mimic MeOH.
purification by analytical RP-HPLC (MeOH/H2O, 3:7, flow rate 2-NBDG Glucose Uptake Assay. HuH7, human hepatoma cells
0.8 mL/min) yielded 4-O-β-D-glucopyranosyl-Z-4-coumaric acid (6, 7 clone 5 (passage 49) (Ceinge Biotecnologie Avanzate, Naples,
4.5 mg, tR 8.8 min) and 1-O-(4-coumaroyl)-β- D-glucopyranose (7, Italy), possess a stable hepatic phenotype and respond well to insulin
77.6 mg, tR 10.6 min). Fraction 49−66 was separated by HPLC stimulation. Cells were cultured in Dulbecco’s modified Eagle
(CH3OH/H2O, 55:45, flow rate 2.5 mL/min) to afford pure medium (DMEM) (41965-039, Gibco, Thermo Fisher Scientific,
compound 4 (111.4 mg, tR 8.1 min). Fraction 67/68 was separated Waltham, MA, USA) supplemented with 10% fetal bovine serum
by HPLC using CH3OH/H2O (50:50, flow rate 2.5 mL/min) to yield (FBS), penicillin, and streptomycin in a cell culture incubator at 37
compound 3 (93.9 mg, tR 8.5 min) and isovitexin-2′-O-β-D- °C and with 5% CO2.
glucopyranoside (5, 39.5 mg, tR 11.3 min). Fraction 69/70 was HuH7 cells were plated (5 × 103/well) in a black, clear-bottom, 96-
separated by HPLC (CH3OH/H2O, 50:50, flow rate 2.0 mL/min) to well microtiter plate (PerkinElmer, USA) in a final volume of 100 μL/
afford pure cissuxinoside (1, 5.4 mg, tR 8.9 min). well of culture medium. Once cells had reached 80−90% confluence,
Cissuxinoside (1): yellow amorphous solid, [α]D −11 (c 0.1, culture medium was carefully removed and replaced with 100 μL of
CH3OH); 1H NMR (methanol-d4, 400 MHz) Table 1; 13C NMR HBSS containing 100 μM 2-DG, 0.4 g/L BSA, and 1.3 mM CaCl2 (in
(methanol-d4, 125 MHz) see Table 1; ESIMS m/z 633 [M − H]−; the absence of any growth factors or FBS). Plates were incubated at
HR-ESIMS m/z found 633.5873 (calcd for C30H33O15 633.5870). 37 °C for 1 h. HBSS was then supplemented with insulin (1, 10, or
Cissoic acid (2): yellowish amorphous solid, [α]D −5 (c 0.1, 100 nM), used as control, or with the test compounds (800 μg/mL)
CH3OH); 1H NMR (methanol-d4, 700 MHz) and 13C NMR or fractions (2.0 mg/mL) dissolved in DMSO. Plates were incubated
(methanol-d4, 175 MHz), see Table 2; ESIMS m/z 429 [M − H]−; for an additional period of 30 min. At the end of this second
HR-ESIMS m/z found 429.4502 (C20H29O10 requires 429.4500). incubation, cell medium was replaced with HBSS containing 100 μM
Vitexin-2″-O-β-D-arabinofuranoside (3): yellow amorphous solid, 2-DG, 0.4 g/L BSA, and 1.3 mM CaCl2 supplemented with 6 μM 2-
[α]D −58.7 (c 0.15, CH3OH); 1H NMR (methanol-d4, 500 MHz) δH NBDG. Plates were incubated with the fluorescent probe for 45 min
8.01 (1H, d, J = 8.2, H-2′, H-6′), 6.94 (1H, d, J = 8.2, H-3′, H-5′), and then washed twice in PBS. Uptake of 2-NDBG was measured in a
6.60 (1H, s, H-3), 6.25 (1H, s, H-6), 5.08 (1H, s, H-1‴), 5.02 (1H, d, PerkinElmer Envision 2105 multiplate reader (PerkinElmer, USA),
J = 10.0, H-1″), 4.28 (1H, dd, J = 9.8, 8.0, H-2″), 3.99 (1H, dd, J = using the in-built monochromator and the following parameters: λ
12.5, 2.0, H-6″a), 3.88 (1H, overlapped, H-6′′b), 3.86 (1H, excitation 471 nm, λ emission 529 nm, monochromator cutoff 360
overlapped, H-2‴), 3.75 (1H, dd, J = 6.3, 3.8, H-3‴), 3.71 (1H, t, J nm. After the measurement of 2-NDBG, cells were fixed in 3.7% PFA
= 9.5, H-4″), 3.71 (1H, t, J = 9.0, H-4″), 3.69 (1H, t, J = 9.0, H-3″), for 30 min and then permeabilized in 0.1% Triton X-100 in PBS and
3.46 (1H, m, H-5′′), 3.28 (1H, dd, J = 12.0, 3.0, H-5‴a), 3.15 (1H, stained with the nuclear dye DAPI (30 μM). This second fluorescence
dd, J = 12.0, 3.0, H-5‴b), 2.70 (1H, m, H-4″′); 1H NMR (DMSO-d6, measurement correlates with the total number of cells in each well
500 MHz) δH 8.04 (2H, d, J = 8.7, H-2′, H-6′), 6.88 (2H, d, J = 8.7, and was used for normalization. DAPI fluorescence was measured
H-3′, H-5′), 6.80 (1H, s, H-3), 6.24 (1H, s, H-6), 4.90 (1H, bs, H- using the following parameters: λ excitation 351 nm, λ emission 450
1‴), 4.74 (1H, d, J = 10.0, H-1″), 4.03 (1H, t, J = 10.0, H-2″), 3.76 nm. Data analysis for glucose uptake is reported as the ratio between
(1H, d, J = 12.0, H-6″a), 3.56 (1H, overlapped, H-2‴), 3.53 (1H, intracellular 2-NDBG fluorescence and DAPI fluorescence ± SD.
■
overlapped, H-3′′′), 3.51 (1H, dd, J = 12.0, 6.3, H-6″b), 3.45 (1H, t, J
= 8.9, H-3″), 3.38 (1H, t, J = 9.4, H-4″), 3.21 (1H, m, H-5′′), 2.99 ASSOCIATED CONTENT
(1H, dd, J = 12.0, 1.9, H-5‴a), 2.87 (1H, dd, J = 12.0, 1.9, H-5‴b),
2.36 (1H, m, H-4″′); 13C NMR (DMSO-d6, 125 MHz) δC 182.5 (C- *
sı Supporting Information
4), 165.1 (C-7), 164.3 (C-2), 161.6 (C-4′), 160.8 (C-5), 156.4 (C-9), The Supporting Information is available free of charge at
129.4 (C-2′, C-6′), 122.1 (C-1′), 116.2 (C-3′, C-5′), 108.1 (C-1‴), https://pubs.acs.org/doi/10.1021/acs.jnatprod.0c00597.
104.6 (C-8), 104.0 (C-10), 102.7 (C-3), 98.4 (C-6), 82.9 (C-2″′),
82.7 (C-4′′′), 82.5 (C-5′′), 79.6 (C-3′′), 75.9 (C-3′′′), 75.0 (C-2′′), 1D and 2D NMR spectra for 1−4 (PDF)
72.3 (C-1′′), 71.1 (C-4′′), 61.6 (C-6′′), 59.2 (C-5′′′); ESIMS m/z
■
563 [M − H]−; HR-ESIMS m/z found 563.5868 (calcd for
C26H27O14 563.5870). AUTHOR INFORMATION
Orientin-2″-O-β-D-arabinofuranoside (4): yellow amorphous
solid, [α]D −38.9 (c 0.18, CH3OH); 1H NMR (methanol-d4, 700 Corresponding Authors
MHz) δH 7.61 (1H, d, J = 2.0, H-2′), 7.56 (1H, dd, J = 8.3, 2.0, H-6′), Orazio Taglialatela-Scafati − Department of Pharmacy,
6.94 (1H, d, J = 8.3, H-5′), 6.57 (1H, s, H-3), 6.26 (1H, s, H-6), 5.08 School of Medicine and Surgery, University of Naples
(1H, s, H-1‴), 5.02 (1H, d, J = 10.0, H-1″), 4.28 (1H, dd, J = 9.8, 8.0, Federico II, 80131 Napoli, Italy; orcid.org/0000-0001-
H-2″), 3.99 (1H, dd, J = 12.5, 2.0, H-6″a), 3.88 (1H, overlapped, H-
8010-0180; Phone: +39-081-678509; Email: scatagli@
6′′b), 3.86 (1H, overlapped, H-2‴), 3.75 (1H, dd, J = 6.3, 3.8, H-3‴),
3.71 (1H, t, J = 9.5, H-4″), 3.71 (1H, t, J = 9.0, H-4″), 3.69 (1H, t, J = unina.it
9.0, H-3″), 3.46 (1H, m, H-5′′), 3.28 (1H, dd, J = 12.0, 3.0, H-5‴a), Shagufta Perveen − Department of Pharmacognosy, College of
3.15 (1H, dd, J = 12.0, 3.0, H-5‴b), 2.70 (1H, m, H-4″′); 13C NMR Pharmacy, King Saud University, Riyadh 11495, Kingdom of
(methanol-d4, 175 MHz) δC 182.7 (C-4), 165.1 (C-2), 163.1 (C-7), Saudi Arabia; Phone: +0966 566390830;
161.2 (C-5), 157.0 (C-9), 149.3 (C-4′), 145.8 (C-3′), C123.1 (C-1′), Email: shakhan@ksu.edu.sa
3303 https://dx.doi.org/10.1021/acs.jnatprod.0c00597
J. Nat. Prod. 2020, 83, 3298−3304
Journal of Natural Products pubs.acs.org/jnp Article
Authors (16) Palme, E.; Bilia, A. R.; De Feo, V.; Morelli, I. Phytochemistry
Jawaher Alqahtani − Department of Pharmacy, School of 1994, 35, 1381−1382.
Medicine and Surgery, University of Naples Federico II, (17) Gidekel, M.; Weber, R. H.; Cafferata, E. G.; Gutierrez, A.;
Sunkel, C.; Osorio Navarro, J. U.S. Pat. Appl. Publ. US20140287074
80131 Napoli, Italy; Department of Pharmacognosy, College A1 20140925, 2014.
of Pharmacy, King Saud University, Riyadh 11495, Kingdom (18) Cheng, G.; Bai, Y.; Zhao, Y.; Tao, J.; Liu, Y.; Tu, G.; Ma, L.;
of Saudi Arabia Liao, N.; Xu, X. Tetrahedron 2000, 56, 8915−920.
Carmen Formisano − Department of Pharmacy, School of (19) Wu, J.; Zhang, S.; Huang, J.; Xiao, Q.; Li, Q.; Long, L.; Huang,
Medicine and Surgery, University of Naples Federico II, L. Chem. Pharm. Bull. 2003, 51, 1201−1203.
80131 Napoli, Italy (20) He, X.; Liu, R. H. J. Agric. Food Chem. 2006, 54, 7069−7074.
Giuseppina Chianese − Department of Pharmacy, School of (21) Vo, V. A.; Lee, J. W.; Kim, J. Y.; Park, J. H.; Lee, H. J.; Kim, S.
Medicine and Surgery, University of Naples Federico II, S.; Kwon, Y. S.; Chun, W. Korean J. Physiol. Pharmacol. 2014, 18, 79−
80131 Napoli, Italy 86.
Paolo Luciano − Department of Pharmacy, School of Medicine (22) Hixson, J. L.; Hayasaka, Y.; Curtin, C. D.; Sefton, M. A.; Taylor,
D. K. J. Agric. Food Chem. 2016, 64, 9401−9411.
and Surgery, University of Naples Federico II, 80131 Napoli,
Italy
Mariano Stornaiuolo − Department of Pharmacy, School of
Medicine and Surgery, University of Naples Federico II,
80131 Napoli, Italy; orcid.org/0000-0003-2200-5083
Complete contact information is available at:
https://pubs.acs.org/10.1021/acs.jnatprod.0c00597
Notes
The authors declare no competing financial interest.
■ ACKNOWLEDGMENTS
This work has been funded by External Joint Supervision
Program (King Saud University, Riyadh, Saudi Arabia) by
means of a grant to J. A. to support her Ph.D. program at the
University of Naples Federico II.
■ REFERENCES
(1) Awadh Ali, N. A.; Al Sokari, S. S.; Gushash, A.; Anwar, S.; Al-
Karani, K.; Al-Khulaidi, A. Pharmacogn. Res. 2017, 9, 401−407.
(2) Al-Fatimi, M.; Wurster, M.; Schröder, G.; Lindequist, U. J.
Ethnopharmacol. 2007, 111, 657−666.
(3) Al-Bukhaiti, W. Q.; Noman, A.; Mahdi, A. A.; Abed, S. M.; Ali,
A. H.; Khaleel, J. M.; Wang, H. J. Food Sci. Technol. 2019, 56, 4844−
4854.
(4) Onyechi, U. A.; Judd, P. A.; Ellis, P. R. Br. J. Nutr. 1998, 80,
419−428.
(5) Pepato, M. T.; Baviera, A. M.; Vendramini, R. C.; da Silva Perez,
M. P. M.; Kettelhut, I. C.; Brunetti, I. L. Biotechnol. Appl. Biochem.
2003, 37, 15−20.
(6) Chipiti, T.; Ibrahim, M. A.; Singh, M.; Islam, M. S. Pharmacogn.
Mag. 2017, 13, S329−S333.
(7) Shalabi, A.; El-Sakhawy, F.; Choucry, M.; El Awdan, S.; Abdel-
Sattar, E. Res. J. Pharm., Biol. Chem. Sci. 2018, 9, 430−440.
(8) Said, A.; Aboutabl, E. A.; Melek, F. R.; Abdel Raheem, G.; Jaleel,
A.; Raslan, M. Trends Phytochem. Res. 2018, 2, 65−74.
(9) Perveen, S.; Alqahtani, J.; Orfali, R.; Al-Taweel, A. M.;
Yusufoglu, H. S.; Abdel-Kader, M. S.; Taglialatela-Scafati, O.
Fitoterapia 2019, 134, 129−134.
(10) Perveen, S.; Alqahtani, J.; Orfali, R.; Aati, H. Y.; Al-Taweel, A.
M.; Ibrahim, T. A.; Khan, A.; Yusufoglu, H. S.; Abdel-Kader, M. S.;
Taglialatela-Scafati, O. Molecules 2020, 25, 1730.
(11) Wang, N.; Yao, X.; Ishii, R.; Kitanaka, S. Phytochemistry 2003,
62, 741−746.
(12) Matsumori, N.; Kaneno, D.; Murata, M.; Nakamura, H.;
Tachibana, K. J. Org. Chem. 1999, 64, 866−876.
(13) Bifulco, G.; Dambruoso, P.; Gomez-Paloma, L.; Riccio, R.
Chem. Rev. 2007, 107, 3744−3779.
(14) MacMillan, J.; Suter, P. J. Tetrahedron 1967, 23, 2417−2419.
(15) Lorenzen, K.; Anke, T.; Sterner, O. Phytochemistry 1996, 43,
791−792.
3304 https://dx.doi.org/10.1021/acs.jnatprod.0c00597
J. Nat. Prod. 2020, 83, 3298−3304